SCHEMBL4458226

SCHEMBL4458226

Nc1ncc(-c2ccc3c(c2)OCCO3)c(N)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 5/20 0.55
CHEK1 O14757 1/20 0.48
CHEK2 O96017 1/20 0.48
MAPT P10636 5/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
TGFBR1 P36897 1/20 0.47
ACVR1 Q04771 1/20 0.47
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
XBP1 P17861 1/20 0.46
KMT2A Q03164 1/20 0.46
HIF1A Q16665 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CD274 Q9NZQ7 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1388344 0.91 DHFR (0.55) DHFRCHEK2MAPTKMT2AHTT
SCHEMBL30329901 0.84 DYRK1A (0.57) DHFRMAPTNPC1RAB9ASMN1; SMN2
Phenol SCHEMBL27612541 0.82 DHFR (0.52) DHFRCHEK2MAPTNPC1RAB9A
SCHEMBL1388281 0.80 DHFR (0.56) DHFRKMT2A
SCHEMBL1076816 0.79 MAPT (0.43) CHEK1CHEK2MAPTNPC1RAB9A
SCHEMBL31579140 0.79 KDM4E (0.54) CHEK1CHEK2MAPTNPC1RAB9A
SCHEMBL27612526 0.78 NPC1 (0.53) DHFRCHEK1CHEK2MAPTNPC1
SCHEMBL978543 0.75 CD274 (0.55) CHEK1CHEK2MAPTNPC1RAB9A
SCHEMBL6440681 0.73 ADORA1 (0.56) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL27631605 0.73 CD274 (0.52) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
CN-102174024-B 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS INC 2015-02-11 CN disclosed
CN-102174024-A 2,4-pyrimidinediamine compounds and their uses RIGEL PHARMACEUTICALS INC 2011-09-07 CN disclosed
CN-1625400-B 2, 4-pyrimidinediamine compounds and uses thereof RIGEL PHARMACEUTICALS INC 2011-04-13 CN disclosed
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed
EP-0674627-A1 PYRIMIDINE, PYRIDINE, PTERIDINONE AND INDAZOLE DERIVATIVES AS ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1995-10-04 EP disclosed
WO-1994014780-A1 PYRIMIDINE, PYRIDINE, PTERIDINONE AND INDAZOLE DERIVATIVES AS ENZYME INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-07-07 WO disclosed